Last Posted: May 11, 2017
Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.
Kolliopoulou Alexandra et al. Omics : a journal of integrative biology 2017 May
CDC Guideline for Prescribing Opioids for Chronic Pain
Institutional profile: University of Florida Health Personalized Medicine Program.
Cavallari Larisa H et al. Pharmacogenomics 2017 Apr 18(5) 421-426
An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.
Mnika Khuthala et al. Omics : a journal of integrative biology 2016 Sep
Parental Perception of Self-Empowerment in Pediatric Pharmacogenetic Testing: The Reactions of Parents to the Communication of Actual and Hypothetical CYP2D6 Test Results.
Adelsperger Sarah et al. Health communication 2016 Aug 1-8
Opioids: Can a Genetic Test Identify an Addict in the Making?
S Gupta. Medpage, May 29, 2016
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.